Free tool
FAERS Monitor: Idose Tr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 218010 or its brand name (Idose Tr, Travoprost). Reports on generic versions are filed under their own applications.
Reports
118
Serious
19
16% of reports
Hospitalization
1
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- medical device removal32
- intraocular pressure increased27
- device dislocation18
- eye pain17
- eye inflammation13
- cystoid macular oedema12
- iritis12
- photophobia8
- vision blurred7
- corneal oedema6
- hyphaema5
- ocular hyperaemia5
- medical device repositioning4
- visual acuity reduced4
- anterior chamber cell3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2024 | 10 |
| 2025 | 47 |
| 2026 | 61 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,041 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| medical device repositioningSignal | 4 | 25489.2 | 9081.5 | 68,297 |
| medical device removalSignal | 32 | 3362.5 | 2492.0 | 102,283 |
| hyphaemaSignal | 5 | 1725.6 | 728.7 | 6,913 |
| cystoid macular oedemaSignal | 12 | 1142.5 | 667.0 | 12,490 |
| anterior chamber cellSignal | 3 | 752.8 | 245.7 | 1,557 |
| iritisSignal | 12 | 706.4 | 412.7 | 7,733 |
| corneal oedemaSignal | 6 | 478.6 | 219.2 | 2,396 |
| intraocular pressure increasedSignal | 27 | 377.4 | 270.8 | 9,747 |
| eye inflammationSignal | 13 | 243.2 | 145.6 | 2,895 |
| photophobiaSignal | 8 | 75.8 | 38.8 | 519 |
| device dislocationSignal | 18 | 73.8 | 48.2 | 1,223 |
| eye painSignal | 17 | 53.7 | 34.6 | 830 |
| visual acuity reducedSignal | 4 | 21.5 | 8.2 | 59 |
| ocular hyperaemiaSignal | 5 | 18.8 | 8.0 | 67 |
| vision blurredSignal | 7 | 9.1 | 4.4 | 43 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.